Nutriband Inc (NTRB)

Nutriband Inc (NTRB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $73.5M; returns 1 day -0.9%, 1 week -7.4%, 1 year -17.7%.

Nutriband Inc. is a biopharmaceutical company primarily focused on the development of a portfolio of transdermal pharmaceutical products. Its core innovation is the proprietary AVERSA™ abuse-deterrent transdermal technology, designed to incorporate aversive agents into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential.

Groups NTRB belongs to

NTRB financial model: income statement, cash flow and balance sheet